Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-19-011640
Filing Date
2019-02-28
Accepted
2019-02-28 19:00:02
Documents
1
Period of Report
2019-02-26

Document Format Files

Seq Description Document Type Size
1 4 a4.html 4  
1 4 a4.xml 4 3935
  Complete submission text file 0001104659-19-011640.txt   5314
Mailing Address 170 N RADNOR CHESTER RD SUITE 250 RADNOR PA 19087
Business Address 170 N RADNOR CHESTER RD SUITE 250 RADNOR PA 19087 484-801-4670
MARINUS PHARMACEUTICALS INC (Issuer) CIK: 0001267813 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O NEKTAR THERAPEUTICS 201 INDUSTRIAL ROAD SAN CARLOS CA 94070
Business Address
Lorianne Masuoka K. (Reporting) CIK: 0001466086 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36576 | Film No.: 19645948